EP2538972 - RECOMBINANT CDV COMPOSITIONS AND USES THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 01.03.2019 Database last updated on 13.11.2024 | |
Former | The patent has been granted Status updated on 23.03.2018 | ||
Former | Grant of patent is intended Status updated on 16.03.2018 | ||
Former | Examination is in progress Status updated on 22.02.2018 | ||
Former | Grant of patent is intended Status updated on 15.10.2017 | ||
Former | Examination is in progress Status updated on 08.02.2017 | Most recent event Tooltip | 01.03.2019 | No opposition filed within time limit | published on 03.04.2019 [2019/14] | Applicant(s) | For all designated states Merial, Inc. 3239 Satellite Boulevard Bldg. 500 Duluth, GA 30096 / US | [2017/38] |
Former [2013/01] | For all designated states Merial Limited 3239 Satellite Blvd. Duluth, GA 30096 / US | Inventor(s) | 01 /
AUDONNET, Jean-Christophe 119, Rue De Crequi 69006 Lyon / FR | 02 /
MINKE, Jules 16 Rue Nicolas Boileau 69960 Corbas / FR | [2013/01] | Representative(s) | D Young & Co LLP 3 Noble Street London EC2V 7BQ / GB | [N/P] |
Former [2018/17] | D Young & Co LLP 120 Holborn London EC1N 2DY / GB | ||
Former [2013/01] | Harding, Charles Thomas D Young & Co LLP 120 Holborn London EC1N 2DY / GB | Application number, filing date | 11707047.4 | 25.02.2011 | [2018/17] | WO2011US26378 | Priority number, date | US20100308620P | 26.02.2010 Original published format: US 308620 P | [2013/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011106743 | Date: | 01.09.2011 | Language: | EN | [2011/35] | Type: | A1 Application with search report | No.: | EP2538972 | Date: | 02.01.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 01.09.2011 takes the place of the publication of the European patent application. | [2013/01] | Type: | B1 Patent specification | No.: | EP2538972 | Date: | 25.04.2018 | Language: | EN | [2018/17] | Search report(s) | International search report - published on: | EP | 01.09.2011 | Classification | IPC: | A61K39/12, A61K39/175, A61K39/205, A61K39/23, C07K14/015, C07K14/12, C07K14/13, C07K14/145, C07K14/165, C12N7/00, C12N7/04, C12N15/86 | [2013/01] | CPC: |
A61K39/12 (EP,KR,US);
A61K48/005 (KR);
A61K39/175 (KR,US);
A61K39/205 (KR);
A61N5/0613 (US);
A61P31/10 (EP);
A61P31/12 (EP);
A61P31/14 (EP);
A61P31/16 (EP);
A61P31/20 (EP);
A61P31/22 (EP);
A61P33/02 (EP);
A61P37/04 (EP);
C07K14/005 (EP,KR,US);
C07K14/535 (EP,KR,US);
C12N7/00 (US);
A61K2039/53 (EP,KR,US);
A61K2039/545 (EP,KR,US);
A61K2039/552 (EP,KR,US);
A61K2039/55522 (EP,KR,US);
C12N2710/24043 (EP,US);
C12N2750/14334 (EP,US);
C12N2760/18422 (EP,US);
C12N2760/18434 (EP,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/01] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | REKOMBINANTE CDV-ZUSAMMENSETZUNGEN UND IHRE VERWENDUNG | [2013/01] | English: | RECOMBINANT CDV COMPOSITIONS AND USES THEREOF | [2013/01] | French: | COMPOSITIONS DE CDV RECOMBINANT ET LEURS UTILISATIONS | [2013/01] | Entry into regional phase | 20.09.2012 | National basic fee paid | 20.09.2012 | Designation fee(s) paid | 20.09.2012 | Examination fee paid | Examination procedure | 19.09.2012 | Amendment by applicant (claims and/or description) | 20.09.2012 | Examination requested [2013/01] | 04.04.2014 | Despatch of a communication from the examining division (Time limit: M04) | 16.06.2014 | Reply to a communication from the examining division | 15.12.2014 | Despatch of a communication from the examining division (Time limit: M04) | 03.03.2015 | Reply to a communication from the examining division | 17.09.2015 | Despatch of a communication from the examining division (Time limit: M04) | 26.11.2015 | Reply to a communication from the examining division | 11.01.2017 | Cancellation of oral proceeding that was planned for 17.01.2017 | 17.01.2017 | Date of oral proceedings (cancelled) | 30.01.2017 | Despatch of a communication from the examining division (Time limit: M02) | 22.03.2017 | Reply to a communication from the examining division | 16.10.2017 | Communication of intention to grant the patent | 06.02.2018 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 16.02.2018 | Fee for grant paid | 16.02.2018 | Fee for publishing/printing paid | 15.03.2018 | Information about intention to grant a patent | 15.03.2018 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 04.04.2014 | Opposition(s) | 28.01.2019 | No opposition filed within time limit [2019/14] | Fees paid | Renewal fee | 27.02.2013 | Renewal fee patent year 03 | 27.02.2014 | Renewal fee patent year 04 | 26.02.2015 | Renewal fee patent year 05 | 26.02.2016 | Renewal fee patent year 06 | 27.02.2017 | Renewal fee patent year 07 | 27.02.2018 | Renewal fee patent year 08 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XYI]US5702919 (NASH RICHARD A [US], et al) [X] 1,7,8,12,15 * abstract * * column 2, line 13 - line 39 * * column 7, line 26 - line 63 * [Y] 2-5,13 [I] 9-11,16-18; | [XYI]WO9749825 (MERIAL SAS [FR], et al) [X] 1,6,8,9,12,14,16,17 * abstract * * page 3, line 20 - line 25 * * page 5, line 5 - line 27 * * examples 7, 8, 11-14 * [Y] 2-5,13 [I] 18; | [XYI]FR2775601 (MERIAL SAS [FR]) [X] 1,6,8,9,12,14,16,17 * abstract * * page 5, line 17 * * page 6, line 16 - page 7, line 1 * * example 2 * [Y] 2-5,13 [I] 18; | [XYI]US6309647 (PAOLETTI ENZO [US], et al) [X] 1,6,8,9,12,14,16,17 * abstract * * column 1, line 8 - line 14 * * column 7, line 5 - line 9 * * column 8, line 3 - line 7 * * column 10, line 26 - line 34 * * examples 14, 16, 18-19, 21-23 * [Y] 2-5,13 [I] 18; | [X]US2005255127 (LOOSMORE SHEENA M [CA], et al) [X] 1-18 * abstract * * paragraph [0144] - paragraph [0146] * * paragraph [0160] *; | [XYI] - FISCHER L ET AL, "Vaccination of puppies born to immune dams with a canine adenovirus-based vaccine protects against a canine distemper virus challenge", VACCINE, ELSEVIER LTD, GB, (20021004), vol. 20, no. 29-30, doi:DOI:10.1016/S0264-410X(02)00344-4, ISSN 0264-410X, pages 3485 - 3497, XP004381813 [X] 1,6,8,9,12,14,16,17 * abstract * * page 3486, column l, line 36 - line 44 * * 2.4 Engineering of expression cassettes.; page 3487 * * 2.5. Cloning of CDV HA and F; page 3487 - page 3488 * * 2.7. Generation of recombinant CAV2 viruses by in vitro recombination.; page 3488 * * 2.10. Vaccination and protection assays.; page 3488 - page 3489 * [Y] 2-5,13 [I] 18 DOI: http://dx.doi.org/10.1016/S0264-410X(02)00344-4 | [A] - NIELSEN LINE ET AL, "Changes in the receptorbinding haemagglutinin protein of wild-type morbilliviruses are not required for adaptation to Vero cells.", VIRUS GENES, (200310), vol. 27, no. 2, ISSN 0920-8569, pages 157 - 162, XP002639102 [A] 1-18 * the whole document * DOI: http://dx.doi.org/10.1023/A:1025724526378 | [XYI] - NASH R A ET AL, "MOLECULAR CLONING AND IN-VIVO EVALUATION OF CANINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR", BLOOD, (1991), vol. 78, no. 4, ISSN 0006-4971, pages 930 - 937, XP002639103 [X] 1,7,8,12,15,17 * abstract * * page 935, column r * [Y] 2-5,13 [I] 9-11,16,18 | [A] - JONES T ET AL, "POTENTIAL ROLE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AS VACCINE ADJUVANT", EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, SPRINGER, WIESBADEN, DE, (19940101), vol. 13, no. SUPPL. 02, doi:DOI:10.1007/BF01973602, ISSN 0934-9723, pages 47 - 53, XP002009623 [A] 1-18 * abstract * * page S49, line 20 - line 30 * * Approaches for Use of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor as a Vaccine Adjuvant.; page S52 * DOI: http://dx.doi.org/10.1007/BF01973602 | by applicant | US2909462 | US4708871 | US5122458 | US5494807 | US5505941 | WO9634109 | US5606024 | US5702919 | WO9816247 | US5756102 | US5846946 | WO9901158 | US6221362 | US6358500 | US6376473 | US6451769 | US6451770 | US6464984 | US6558674 | US6576243 | US6586412 | US2004022605 | US6818628 | US6852705 | US6919084 | US7250161 | US7371395 | - FENNER ET AL., Veterinary Virology, ACADEMIC PRESS, INC., (1987), pages 485 - 503 | - GRAVES ET AL., VIROLOGY, (1978), vol. 86, pages 254 - 263 | - DIALLO A., VET. MICRO., (1990), vol. 23, pages 155 - 163 | - BURGESS ET AL., J. BIOL. CHEM., (1977), vol. 252, pages 1998 - 2003 | - DY M., les Cytokines, MASSON, (1995), pages 43 - 56 | - CANTRELL ET AL., PROC. NATL. ACAD. SCI. USA, (1985), vol. 82, pages 6250 - 6254 | - PHARMEUROPA, (199606), vol. 8, no. 2 |